메뉴 건너뛰기




Volumn 39, Issue 2, 2012, Pages 1683-1689

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK

Author keywords

Bufalin; Hepatocellular carcinoma; Sorafenib; Synergistic effect

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BUFALIN; CHOLECYSTOKININ OCTAPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SORAFENIB; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; BUFADIENOLIDE DERIVATIVE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PYRIDINE DERIVATIVE;

EID: 84860335274     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0908-x     Document Type: Article
Times cited : (31)

References (29)
  • 3
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • DOI 10.1002/hep.20933
    • Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236 (Pubitemid 43112690)
    • (2005) Hepatology , vol.42 , Issue.5 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 4
    • 0141491273 scopus 로고    scopus 로고
    • Hepatocellular carcinoma
    • DOI 10.1016/S0140-6736(03)14964-1
    • Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917 (Pubitemid 37518510)
    • (2003) Lancet , vol.362 , Issue.9399 , pp. 1907-1917
    • Llovet, J.M.1    Burroughs, A.2    Bruix, J.3
  • 5
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378-390
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 6
    • 57749189578 scopus 로고    scopus 로고
    • Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial
    • Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25-34
    • (2009) Lancet Oncol , vol.10 , pp. 25-34
    • Cheng, A.L.1    Kang, Y.K.2    Chen, Z.3
  • 7
    • 77649228957 scopus 로고    scopus 로고
    • Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: A phase I/II study
    • Zhao JD, Liu J, Ren ZG et al (2010) Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity- modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol 5:12-18
    • (2010) Radiat Oncol , vol.5 , pp. 12-18
    • Zhao, J.D.1    Liu, J.2    Ren, Z.G.3
  • 8
    • 0014187807 scopus 로고
    • Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: In vitro and in vivo studies
    • Shiratori O (1967) Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies. Gann 58:521-528
    • (1967) Gann , vol.58 , pp. 521-528
    • Shiratori, O.1
  • 9
    • 46449105600 scopus 로고    scopus 로고
    • Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells
    • Takai N, Ueda T, Nishida M et al (2008) Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med 21:637-643
    • (2008) Int J Mol Med , vol.21 , pp. 637-643
    • Takai, N.1    Ueda, T.2    Nishida, M.3
  • 11
    • 0037304261 scopus 로고    scopus 로고
    • Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells
    • DOI 10.1002/pros.10172
    • Yeh JY, Huang WJ, Kan SF et al (2003) Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 54:112-124 (Pubitemid 36120327)
    • (2003) Prostate , vol.54 , Issue.2 , pp. 112-124
    • Yeh, J.-Y.1    Huang, W.J.2    Kan, S.-F.3    Wang, P.S.4
  • 13
    • 38149063511 scopus 로고    scopus 로고
    • Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu
    • Yang Z, Luo H, Wang H et al (2008) Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu. J Chromatogr Sci 46:81-85
    • (2008) J Chromatogr Sci , vol.46 , pp. 81-85
    • Yang, Z.1    Luo, H.2    Wang, H.3
  • 14
    • 76549129820 scopus 로고    scopus 로고
    • Drug combination studies and their synergy quantification using the Chou-Talalay method
    • Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440-446
    • (2010) Cancer Res , vol.70 , pp. 440-446
    • Chou, T.C.1
  • 15
    • 79951578559 scopus 로고    scopus 로고
    • Calreticulin expression levels and endoplasmic reticulum during late oogen-esis and early embryogenesis of Rhodnius prolixus Stahl
    • doi:10.1007/s11033-010-0290-0
    • Ramos IB, Campos CB, Sorgine MH et al (2011) Calreticulin expression levels and endoplasmic reticulum during late oogen-esis and early embryogenesis of Rhodnius prolixus Stahl. Mol Biol Rep 38(3):1757-1767. doi:10.1007/s11033- 010-0290-0
    • (2011) Mol Biol Rep , vol.38 , Issue.3 , pp. 1757-1767
    • Ramos, I.B.1    Campos, C.B.2    Sorgine, M.H.3
  • 16
    • 58149376548 scopus 로고    scopus 로고
    • Molecular mechanisms of hepatocellular carcinoma
    • Aravalli RN, Steer CJ, Cressman EN (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48:2047-2063
    • (2008) Hepatology , vol.48 , pp. 2047-2063
    • Aravalli, R.N.1    Steer, C.J.2    Cressman, E.N.3
  • 18
    • 55749088393 scopus 로고    scopus 로고
    • Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
    • Wilhelm SM, Adnane L, Newell P et al (2008) Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther 7:3129-3140
    • (2008) Mol Cancer Ther , vol.7 , pp. 3129-3140
    • Wilhelm, S.M.1    Adnane, L.2    Newell, P.3
  • 19
    • 70049099306 scopus 로고    scopus 로고
    • Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: Evidence from an in vitro study
    • Zhang Z, Zhou X, Shen H et al (2009) Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. BMC Med 7:41
    • (2009) BMC Med , vol.7 , pp. 41
    • Zhang, Z.1    Zhou, X.2    Shen, H.3
  • 20
    • 67649438633 scopus 로고    scopus 로고
    • Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepato-cellular carcinoma cells
    • Dai R, Chen R, Li H (2009) Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepato-cellular carcinoma cells. Int J Oncol 34:1749-1757
    • (2009) Int J Oncol , vol.34 , pp. 1749-1757
    • Dai, R.1    Chen, R.2    Li, H.3
  • 22
    • 80052746970 scopus 로고    scopus 로고
    • Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 cells
    • doi: 10.1093/ecam/nep082 (in press)
    • Sun L, Chen T, Wang X et al (2009) Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 cells. Evid Based Complement Alternat Med doi: 10.1093/ecam/nep082 (in press)
    • (2009) Evid Based Complement Alternat Med
    • Sun, L.1    Chen, T.2    Wang, X.3
  • 23
    • 57349119864 scopus 로고    scopus 로고
    • PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells
    • Li D, Qu X, Hou K et al (2009) PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs 20:59-64
    • (2009) Anticancer Drugs , vol.20 , pp. 59-64
    • Li, D.1    Qu, X.2    Hou, K.3
  • 24
    • 56849086301 scopus 로고    scopus 로고
    • AKT and oxidative stress team up to kill cancer cells
    • Dolado I, Nebreda AR (2008) AKT and oxidative stress team up to kill cancer cells. Cancer Cell 14:427-429
    • (2008) Cancer Cell , vol.14 , pp. 427-429
    • Dolado, I.1    Nebreda, A.R.2
  • 25
    • 56849118516 scopus 로고    scopus 로고
    • Akt determines rep-licative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis
    • Nogueira V, Park Y, Chen CC et al (2008) Akt determines rep-licative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458-470
    • (2008) Cancer Cell , vol.14 , pp. 458-470
    • Nogueira, V.1    Park, Y.2    Chen, C.C.3
  • 26
    • 63649129676 scopus 로고    scopus 로고
    • Coadministration of so-rafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro
    • Chen FS, Cui YZ, Luo RC et al (2008) Coadministration of so-rafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 28:1684-1687
    • (2008) Nan Fang Yi Ke da Xue Xue Bao , vol.28 , pp. 1684-1687
    • Chen, F.S.1    Cui, Y.Z.2    Luo, R.C.3
  • 27
    • 63149135554 scopus 로고    scopus 로고
    • Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells
    • Wu J, Luo RC, Zhang H et al (2008) Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao 28:639-641
    • (2008) Nan Fang Yi Ke da Xue Xue Bao , vol.28 , pp. 639-641
    • Wu, J.1    Luo, R.C.2    Zhang, H.3
  • 28
    • 79955755223 scopus 로고    scopus 로고
    • Schedule-dependent effects of sorafenib in combination with paclitaxel on human hepatocellular carcinoma cell line BEL-7402
    • Li N, Zhang Y, Wu T et al (2009) Schedule-dependent effects of sorafenib in combination with paclitaxel on human hepatocellular carcinoma cell line BEL-7402. Ai Zheng 28:838-843
    • (2009) Ai Zheng , vol.28 , pp. 838-843
    • Li, N.1    Zhang, Y.2    Wu, T.3
  • 29
    • 52649085241 scopus 로고    scopus 로고
    • Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma
    • Wang Z, Zhou J, Fan J et al (2008) Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 14:5124-5130
    • (2008) Clin Cancer Res , vol.14 , pp. 5124-5130
    • Wang, Z.1    Zhou, J.2    Fan, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.